Pretransplantation Cardiac Workup of the Kidney Transplant Recipient for Coronary Heart Disease

被引：0

作者：

Trivedi, Mayuri ^{[1
]}

Siodia, Kayan ^{[2
]}

机构：

[1] Lokmanya Tilak Municipal Gen Hosp, Dept Nephrol, Mumbai, Maharashtra, India

[2] SL Raheja Hosp, Dept Cardiol, Mumbai, Maharashtra, India

来源：

INDIAN JOURNAL OF TRANSPLANTATION | 2024年 / 18卷 / 03期

关键词：

Cardiac disease; cardiac screening; kidney transplant; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; SCIENTIFIC STATEMENT; AMERICAN-COLLEGE; FOCUSED UPDATE; ASSOCIATION; CANDIDATES; MANAGEMENT; EVENTS; RISK;

D O I：

10.4103/ijot.ijot_85_23

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

As the prevalence of chronic kidney disease (CKD) increases globally, a greater number of CKD patients are surviving to become end-stage kidney disease (ESKD) and avail kidney transplantation as means of therapy. Furthermore, with the global mismatch of demand and supply of organs, a large number of ESKD patients remain on the waitlist of deceased donor renal transplantation for longer times. The risk of cardiovascular diseases (CVD) rises exponentially with advancing stages of CKD. The elevated risk in these patients also accounts for CVD as the leading cause of mortality in these patients as compared to the underlying kidney disease. Wherein, there is ample justification for pretransplantation screening of a potential transplantation recipient, the benefits of such screening remain unproven in literature. In this narrative review, we discuss the uncertainties associated with pretransplantation cardiac screening including the appropriate tests, the interpretation of their results, and the complications of the same and deal with the cardiac screening pertaining predominantly to coronary heart disease.

引用

页码：240 / 246

页数：7

共 38 条

[1]

Jankowski J, Floege J, Fliser D, Bohm M, Marx N., Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options, Circulation, 143, (2021)

[2]

Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyerberg EW, Et al., Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index, Am J Med, 118, (2005)

[3]

Rankin AJ, Mark PB., Cardiac screening prior to renal transplantation‑ good intentions, rather than good evidence, dictate practice, Kidney Int, 99, (2021)

[4]

Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Et al., Chronic kidney disease and coronary artery disease: JACC state‑of‑the‑art review, J Am Coll Cardiol, 74, pp. 1823-1838, (2019)

[5]

Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Et al., Coronary‑artery calcification in young adults with end‑stage renal disease who are undergoing dialysis, N Engl J Med, 342, (2000)

[6]

Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Et al., European Renal and Cardiovascular Medicine (EURECA‑m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA‑EDTA). The systemic nature of CKD, Nat Rev Nephrol, 13, pp. 344-358, (2017)

[7]

Wang Z, Jiang A, Wei F, Chen H., Cardiac valve calcification and risk of cardiovascular or all‑cause mortality in dialysis patients: A meta‑ analysis, BMC Cardiovasc Disord, 18, (2018)

[8]

Kasiske BL, Maclean JR, Snyder JJ., Acute myocardial infarction and kidney transplantation, J Am Soc Nephrol, 17, pp. 900-907, (2006)

[9]

Nimmo A, Forsyth JL, Oniscu GC, Robb M, Watson C, Fotheringham J, Et al., A propensity score–matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients, Kidney Int, 99, (2021)

[10]

Bangalore S, Maron DJ, O'Brien SM, Fleg JL, Kretov EI, Briguori C, Et al., ISCHEMIA‑CKD Research Group. Management of Coronary Disease in Patients with Advanced Kidney Disease, N Engl J Med, 382, (2020)

← 1 2 3 4 →